Skip to main content
Top
Published in: Diabetes Therapy 1/2019

Open Access 01-02-2019 | Insulins | Original Research

Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes

Authors: Asma Deeb, Layla Abdelrahman, Mary Tomy, Shaker Suliman, Mariette Akle, Mike Smith, Ken Strauss

Published in: Diabetes Therapy | Issue 1/2019

Login to get access

Abstract

Introduction

Proper insulin injection/infusion is essential to optimize insulin absorption and action. Guidelines on insulin injection techniques are available. Lipohypertrophy (LH) is a local complication of insulin therapy, which results in erratic absorption and impaired glycemic control.

Methods

Children and adults with type 1 diabetes on insulin injection or infusion were enrolled in the study. Subjects were interviewed and filled in a questionnaire on injection/infusion routines. Sites of injection/infusion were examined by trained diabetes educators, and capillary HbA1c was obtained.

Results

One hundred sixty-nine subjects (104 children) with type 1 diabetes were enrolled; 119 were on multiple daily injection (MDI) and 50 on insulin pump therapy. Seventy-two percent and 82% of children and adults, respectively, rotate site at every injection; 78% of pump users change infusion set and 74% rotate site at 2–3 days. Thirty-nine percent and 32% of children and adults had LH. HbA1c was lower in children and adults with no LH (P < 0.001). An association was seen between LH and rotation frequency in children (P = 0.026). LH was the most common skin complication in the MDI group, while nodules, allergy marks and hyperpigmentation were seen in pump users.

Conclusion

Proper injection/infusion routines impact glycemic control and skin health. Education and examination of injection sites remain a crucial part of diabetes management.
Literature
1.
go back to reference Guerci B, Sauvanet JP. Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabetes Metab. 2005;31:4S7–4S24. Guerci B, Sauvanet JP. Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabetes Metab. 2005;31:4S7–4S24.
2.
go back to reference Frid AH, Kerugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, Smith MJ, Welhoener R, Bode BW, Hirsch IB, Karla S, Ji L, Strauss KW. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–55.CrossRef Frid AH, Kerugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, Smith MJ, Welhoener R, Bode BW, Hirsch IB, Karla S, Ji L, Strauss KW. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–55.CrossRef
3.
go back to reference Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: injecting complications and role of the professional. Mayo Clin Proc. 2016;91(9):1224–30.CrossRef Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: injecting complications and role of the professional. Mayo Clin Proc. 2016;91(9):1224–30.CrossRef
4.
go back to reference Partanen TM, Rissanen A. Insulin injection practices. Pract Diab Int. 2000;17:252–4.CrossRef Partanen TM, Rissanen A. Insulin injection practices. Pract Diab Int. 2000;17:252–4.CrossRef
5.
go back to reference Strollo F, Gentile S. Comment on the new Indian injection technique recommendations: critical appraisal of the real-world implementation of the current guidelines. Diabetes Ther. 2017;8(3):507–11.CrossRef Strollo F, Gentile S. Comment on the new Indian injection technique recommendations: critical appraisal of the real-world implementation of the current guidelines. Diabetes Ther. 2017;8(3):507–11.CrossRef
6.
go back to reference Fujikura J, Fujimoto M, Yasue S, Noguchi M, et al. Insulin-induced LH: report of a case with histopathology. Endocr J. 2005;52(5):623–8.CrossRef Fujikura J, Fujimoto M, Yasue S, Noguchi M, et al. Insulin-induced LH: report of a case with histopathology. Endocr J. 2005;52(5):623–8.CrossRef
7.
go back to reference Gentile S, Strollo F, Della Corte TD, Marino G, Guarino G, the Italian Study Group on Injection Techniques. Skin complications of insulin injections: a case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract. 2018;138:284–287. Gentile S, Strollo F, Della Corte TD, Marino G, Guarino G, the Italian Study Group on Injection Techniques. Skin complications of insulin injections: a case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract. 2018;138:284–287.
8.
go back to reference Ginsberg B, Strauss K. Has RoboCop got diabetes? Response to Berger et al. Diabetes Care. 2004;27:1851–2. Ginsberg B, Strauss K. Has RoboCop got diabetes? Response to Berger et al. Diabetes Care. 2004;27:1851–2.
9.
go back to reference Look D, Strauss K. Nadeln mehrfach verwenden? Diab J. 1998;10:S31–4. Look D, Strauss K. Nadeln mehrfach verwenden? Diab J. 1998;10:S31–4.
10.
go back to reference Misnikova IV, Dreval AV, Gubkina1 VA, Rusanov EV. The Risk of repeated use of insulin pen needles. J Diab. 2011;1:1. Misnikova IV, Dreval AV, Gubkina1 VA, Rusanov EV. The Risk of repeated use of insulin pen needles. J Diab. 2011;1:1.
11.
go back to reference Paily R. Perinephral abscess from insulin syringe reuse. Am J Med Sci. 2004;327:47–8.CrossRef Paily R. Perinephral abscess from insulin syringe reuse. Am J Med Sci. 2004;327:47–8.CrossRef
12.
go back to reference Thow JC, Johnson AB, Marsden S, Taylor R, Home PH. Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diab Med. 1990;7:795–9.CrossRef Thow JC, Johnson AB, Marsden S, Taylor R, Home PH. Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diab Med. 1990;7:795–9.CrossRef
13.
go back to reference Teft G. LH: patient awareness and implications for practice. J Diab Nurs. 2002;6:20–3. Teft G. LH: patient awareness and implications for practice. J Diab Nurs. 2002;6:20–3.
14.
go back to reference Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced LH. BMJ. 2003;327:383–4.CrossRef Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced LH. BMJ. 2003;327:383–4.CrossRef
15.
go back to reference Famulla S, Hövelmann U, Fische A, et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diab Care. 2016;39:486.CrossRef Famulla S, Hövelmann U, Fische A, et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diab Care. 2016;39:486.CrossRef
16.
go back to reference Conwell LS, Pope E, Artiles AM, Mohanta A, Daneman A, Daneman D. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr. 2008;152(5):622–8.CrossRef Conwell LS, Pope E, Artiles AM, Mohanta A, Daneman A, Daneman D. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr. 2008;152(5):622–8.CrossRef
17.
go back to reference Schober E, Rami B. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children. Pediatr Diab. 2009;10:198–201.CrossRef Schober E, Rami B. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children. Pediatr Diab. 2009;10:198–201.CrossRef
18.
go back to reference Pickup JC, Yemane N, Brackenridge A, Pender S. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diab Tech Ther. 2014;16(3):145–9.CrossRef Pickup JC, Yemane N, Brackenridge A, Pender S. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diab Tech Ther. 2014;16(3):145–9.CrossRef
19.
go back to reference Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F, AMD-OSDI Italian Injection Technique Study Group. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. Springer plus. 2016;5:563. Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F, AMD-OSDI Italian Injection Technique Study Group. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. Springer plus. 2016;5:563.
20.
go back to reference Omar MA, El-Kafoury AA, El-Araby RI. LH in children and adolescents with type 1 diabetes and the associated factors. BMC Res Notes. 2011;4:290.CrossRef Omar MA, El-Kafoury AA, El-Araby RI. LH in children and adolescents with type 1 diabetes and the associated factors. BMC Res Notes. 2011;4:290.CrossRef
21.
go back to reference Seyoum B, et al. Systematic inspection of insulin injection sites for local complications related to correct injection technique. Trop Doct. 1996;26:159–61.CrossRef Seyoum B, et al. Systematic inspection of insulin injection sites for local complications related to correct injection technique. Trop Doct. 1996;26:159–61.CrossRef
22.
go back to reference Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of LH in insulin-injecting patients with diabetes. Diab Metab. 2013;39(5):445–53.CrossRef Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of LH in insulin-injecting patients with diabetes. Diab Metab. 2013;39(5):445–53.CrossRef
23.
go back to reference Vardar, et al. Incidence of LH in diabetic patients and a study of influencing factors. Diabetes Rec Clin Pract. 2007;77:231–6.CrossRef Vardar, et al. Incidence of LH in diabetic patients and a study of influencing factors. Diabetes Rec Clin Pract. 2007;77:231–6.CrossRef
24.
go back to reference Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71–6.CrossRef Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71–6.CrossRef
25.
go back to reference Clausen TS, Kaastrup P, Stallknecht B. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diab Technol Ther. 2009;11(9):575–80.CrossRef Clausen TS, Kaastrup P, Stallknecht B. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diab Technol Ther. 2009;11(9):575–80.CrossRef
26.
go back to reference Kalra S, Hirsch LJ, Frid A, Deeb A, Strauss KW. Pediatric insulin injection technique: a multi-country survey and clinical practice implications. Diabetes Ther. 2018;9(6):2291–302.CrossRef Kalra S, Hirsch LJ, Frid A, Deeb A, Strauss KW. Pediatric insulin injection technique: a multi-country survey and clinical practice implications. Diabetes Ther. 2018;9(6):2291–302.CrossRef
Metadata
Title
Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes
Authors
Asma Deeb
Layla Abdelrahman
Mary Tomy
Shaker Suliman
Mariette Akle
Mike Smith
Ken Strauss
Publication date
01-02-2019
Publisher
Springer Healthcare
Keywords
Insulins
Insulins
Published in
Diabetes Therapy / Issue 1/2019
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-018-0561-7

Other articles of this Issue 1/2019

Diabetes Therapy 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.